SAN DIEGO, Sept. 8, 2008 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka Securities Exchange (Code Number: 4875), today announced that Dr. Michael Kalafer, Chief Medical Officer, and Shintaro Asako, Chief Financial Officer, of MediciNova will present a company overview at Merriman Curhan Ford’s 5th Annual Investor Summit 2008 on Monday, September 15, 2008, at 11:15 a.m. Pacific time (2:15 p.m. Eastern time). The conference is being held at the Mark Hopkins InterContinental Hotel in San Francisco, California.